Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
Elemental Analyzer Enables Comprehensive Analysis
Thursday, November 24, 2016
Thermo Scientific FlashSmart Elemental Analyzer allows comprehensive analysis for a wide range of applications.
Rainin TerraRacks Enhance Process Security for CROs
Monday, November 07, 2016
METTLER TOLEDO reports on Pelago Bioscience using their Rainin TerraRack pipette tip racks.
Peli BioThermal To Exhibit At Key European Pharma Logistics Show
Friday, October 07, 2016
Company will be showcasing a range of innovative thermal shippers at the forthcoming PDA Europe Pharmaceutical Cold & Supply Chain Logistics.
Acusera Live Online Version 1.6
Wednesday, September 28, 2016
We are delighted to announce the launch of Acusera 24.7 Live Online Version 1.6, now featuring the automatic calculation of Measurement Uncertainty, Total Error and Sigma Metrics as part of our ongoing growth and development.
CRF Health Enhances TrialManager for Intelligent eCOA Reporting & Data Visualization
Tuesday, May 31, 2016
CRF Health announces reporting enhancements to TrialManager®, its real-time portal for the analysis and management of data collected in clinical trials.
North West EHealth’s Unique Linked Database System Used in Salford Lung Study
Thursday, May 26, 2016
North West EHealth’s Unique Linked Database System ensures rapid patient recruitment and reduces clinical development time and costs.
CRF Health Launches TrialConsent, a TrialMax Platform Extension
Tuesday, May 17, 2016
CRF Health launches TrialConsent™, an industry-first electronic informed consent solution fully integrated within an eCOA platform
Centrifugal Evaporator for Contract Research Organisations
Monday, April 25, 2016
The EZ-2 Elite centrifugal evaporator from Genevac, an evaporator of choice for large Pharma R&D, uniquely combines high performance, versatility, ease-of-use and affordability making it the perfect workhorse system for Contract Research Organisations (CRO's).
Global Effort to Develop New Diabetes Treatment
Tuesday, April 12, 2016
CRF Health announces that its TrialMax® eCOA platform has been selected by a leading sponsor in the field of diabetes research.
Showing Results 1 - 10 of 330
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Lynparza Phase III Progression-Free Survival Benefit
AstraZeneca announces results from Phase III SOLO-2 trial designed to determine the efficacy of Lynparza as a monotherapy for ovarian cancer.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
4,000+ scientific and medical posters
5,300+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!